Considerations for RT-qPCR in molecular point of care testing devices

Considerations for RT-qPCR in molecular point of care testing devices

The COVID-19 pandemic has accelerated the uptake of point of care testing (POCT), with simple, user-administered tests becoming commonplace in schools, places of work and people’s homes. Antigen POCT has been pivotal in SARS-CoV-2 detection, particularly where reverse transcription PCR (RT-PCR) cannot be delivered in a timely manner. However, the use of antigen tests isn’t always appropriate due to variable sensitivity. RT-PCR – or RT-qPCR if using real-time detection – offers greater sensitivity and specificity. Leveraging this technology in POCT brings lab quality results to the point of need, providing rapid, accurate and actionable results to clinicians.

Read more

The BiosearchTech Blog

Most popular

Pandemic reflections: Adapting to a constant flux in testing priorities

Posted on Tue, Apr 05, 2022 @ 02:55 PM

What’s changed for clinical labs as we enter the third year of COVID-19 testing? COVID-19, the illness caused by ...
Read more

Topics: Coronavirus, SARS-CoV-2

Society can’t handle the caveats to each type of COVID-19 test

Posted on Fri, Feb 11, 2022 @ 02:58 PM

But measurement science could help steer us in a better, more informed direction COVID-19 tests can indicate the ...
Read more

Topics: qPCR, Coronavirus, SARS-CoV-2

Pandemic reflections: in the face of SARS-CoV-2 variants, COVID-19 testing remains essential

Posted on Tue, Jan 11, 2022 @ 10:00 AM

What’s changed for clinical labs as we enter the third year of COVID-19 testing? COVID-19, the illness caused by ...
Read more

Topics: Coronavirus, SARS-CoV-2, Variants

Pandemic reflections: unprecedented demand drives COVID-19 test developers to get creative

Posted on Tue, Dec 28, 2021 @ 07:30 AM

What’s changed for clinical labs as we enter the third year of COVID-19 testing? COVID-19, the illness caused by ...
Read more

Topics: Coronavirus, SARS-CoV-2

Technical bulletin: Omicron impact on SARS-CoV-2 mutation analysis and investigation

Posted on Thu, Dec 23, 2021 @ 09:45 AM

The emergence of the Omicron lineage has quickly escalated to be a variant of concern by the World Health Organization ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2, Variants

Pandemic reflections: the world is short staffed

Posted on Tue, Dec 21, 2021 @ 04:52 PM

What’s changed for clinical labs as we enter the third year of COVID-19 testing?
Read more

Topics: Coronavirus, SARS-CoV-2

Ensuring our diagnostic assays detect the Omicron variant

Posted on Thu, Dec 09, 2021 @ 02:24 PM

On 22 November 2021, The Network for Genomics Surveillance in South Africa detected a new SARS-CoV-2 variant, named the ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2, Variants

Streamlining diagnostic workflows for common respiratory diseases, such as SARS-CoV-2, influenza and RSV

Posted on Tue, Nov 30, 2021 @ 02:29 PM

A fourth wave of COVID-19 has already emerged in many countries and a newly classified variant of concern, Omicron ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2, Variants, Pathogen detection

Technical bulletin: SARS-CoV-2 mutation analysis and investigation

Posted on Thu, Oct 14, 2021 @ 03:01 PM

SARS-CoV-2 mutations and associated new variants are being reported regularly in the media and scientific literature. ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2, Variants

Can COVID-19 testing be made more sustainable during prolonged uncertainty?

Posted on Mon, Sep 27, 2021 @ 12:36 PM

In September 2021, Delta persists as the most prevalent variant worldwide1 due to its high infectivity, causing surges ...
Read more

Topics: Molecular Diagnostics, High-Throughput, SARS-CoV-2

Wastewater surveillance: a critical tool in pandemic management

Posted on Tue, Aug 31, 2021 @ 07:48 AM

As SARS-CoV-2 variants continue to threaten public health, officials are looking beyond clinical tests to track ...
Read more

Topics: Coronavirus, SARS-CoV-2, Variants

Technical bulletin: Emerging SARS-CoV-2 mutations and their effect on the immune response

Posted on Wed, Aug 18, 2021 @ 01:45 PM

Emerging SARS-CoV-2 variants of concern and variants of interest are defined by agencies such as the World Health ...
Read more

Topics: Coronavirus, SARS-CoV-2, Variants

Genomic surveillance: 3 techniques to detect and characterise SARS-CoV-2 variants

Posted on Wed, May 19, 2021 @ 09:34 AM

As the global population gains greater access to vaccines for COVID-19, scientists and health officials continue to ...
Read more

Topics: Molecular Diagnostics, Genomics, Coronavirus, MDx, SARS-CoV-2, Variants

How do SARS-CoV-2 variants affect PCR assays for COVID-19 testing?

Posted on Tue, May 04, 2021 @ 09:03 AM

Researchers have identified several variants of SARS-CoV-2 since they sequenced the original viral strain responsible ...
Read more

Topics: Molecular Diagnostics, Coronavirus, MDx, SARS-CoV-2, Variants

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!